News

September 20, 2017 03:32 PM Eastern Daylight Time SAN DIEGO–(BUSINESS WIRE)–BTS Research announced today that they have appointed Ian Dean as their VP of Toxicology. Ian has over 27 years in the nonclinical contract research industry, with experience across UK, Canada, Asia and the US. In addition, Ian had various responsibilities in previous CRO’s such…

BIO-QUANT ANNOUNCES THE EXPANSION OF ITS RESEARCH ANIMAL DIAGNOSTIC SERVICES TO COVER ALL NINE SPECIES. SAN DIEGO, CA, September, 2008 –Bio-Quant Inc (“Bio-Quant”) the largest biotech Contract Research Organization (CRO) in San Diego, announced today the expansion of its animal diagnostic services division to cover all nine species used in research. Dr. Bassam Damaj, Chief…

BIO-QUANT credited in TRIUS POSTER.

BIO-QUANT credited in XOMA POSTER.

Bio3 Research S.r.l. (Milano – Italy), is pleased to announce the positive preclinical studies outcome (conducted by the CRO Bio-Quant Inc. La Jolla/CA) obtained with HMGB1 in wound healing in mice and pigs (Vehicle and PDGF as control) which confirms the protein high potential in tissue remodeling. HMGB1 project has demonstrated in-vitro and in-vivo the…

Los Angeles, CA. November 9, 2009 — BioTox Sciences Attends the American Association of Pharmaceutical Scientist Annual Meeting and Exposition in Los Angeles, California.

San Francisco, CA. June 16 – BioTox Sciences attends the International Society for Stem Cell Research Annual Meeting in San Francisco, California at the Moscone Center West.

Baltimore, MD. November 7-10, 2010 – BioTox Sciences attends the American College of Toxicology’s Annual Meeting in Baltimore, Maryland.

Washington, D.C. March 6, 2011 – BioTox Sciences attends the Society of Toxicology: Annual Meeting and Toxicology Expo at the Walter E. Washington Convention Center.